# Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit Page: https://stenobird.com/podcast/breast-cancer-update-757579/triple-negative-breast-cancer-fifth-annual-national-general-medical-oncology-summit Text version: https://stenobird.com/podcast/breast-cancer-update-757579/triple-negative-breast-cancer-fifth-annual-national-general-medical-oncology-summit.md Podcast: [Breast Cancer Update](https://stenobird.com/podcast/breast-cancer-update-757579) Published: 2026-06-20T21:00:00+00:00 Episode link: https://breast-oncology.captivate.fm/episode/6009-gmo26-tnbc Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/e684ced6-5032-4ce3-8aa8-a882f0dadc84.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/triple-negative-breast-cancer-fifth-annual-national-general-medical-oncology-summit Duration seconds: 2959 ## Resource Featuring perspectives from Dr Adam M Brufsky and Dr Kevin Kalinsky, including the following topics: Introduction (0:00) Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Therapy for Triple-Negative Breast Cancer (TNBC) — Dr Brufsky (5:08) Established Treatment Paradigm for Localized and Metastatic TNBC — Dr Kalinsky (35:20) CME information and select publications ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/triple-negative-breast-cancer-fifth-annual-national-general-medical-oncology-summit/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/breast-cancer-update-757579/triple-negative-breast-cancer-fifth-annual-national-general-medical-oncology-summit.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.